Tapderimotide

Tapderimotide (hTERT (691–705) ) is an immunological agent for active immunization[1][2].

Product Specifications

CAS Number

[1221082-45-6]

Product Name Alternative

HTERT (691–705)

UNSPSC

12352209

Target

Others

Type

Peptides

Related Pathways

Others

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/tapderimotide.html

Solubility

10 mM in DMSO

Smiles

O=C([C@H]1N(CCC1)C([C@H](CC(O)=O)NC([C@H](CCC(N)=O)NC([C@H](C)NC([C@H](CCCNC(N)=N)NC([C@H](C(C)C)NC([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@H](C(C)C)NC([C@@H](NC([C@H]([C@H](O)C)NC([C@@H](N)CCCNC(N)=N)=O)=O)CC2=CC=CC=C2)=O)=O)=O)=O)=O)=O)=O)=O)=O)N3[C@@H](CCC3)C(N4[C@@H](CCC4)C(N[C@H](C(O)=O)CCC(O)=O)=O)=O

Molecular Formula

C79H129N25O22

Molecular Weight

1781.02

References & Citations

[1]Robertson JS, et al. International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety. Vaccine. 2022;40 (1) :21-27.|[2]Mizukoshi E, et al. Telomerase-Targeted Cancer Immunotherapy. Int J Mol Sci. 2019;20 (8) :1823. Published 2019 Apr 12.